Dolby Laboratories (DLB) Cash & Equivalents (2009 - 2026)

Dolby Laboratories' Cash & Equivalents history runs 18 years deep, the most recent figure standing at $79.5 million for Q1 2026.

• Quarterly Cash & Equivalents fell 87.31% year-over-year to $79.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $79.5 million (down 87.31% YoY) and the FY2025 annual result came in at $701.9 million, up 633.39% from the prior year.
• Cash & Equivalents was $79.5 million for Q1 2026 at Dolby Laboratories, down from $643.8 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $858.9 million in Q3 2022 and bottomed at $5.0 million in Q1 2023.
• A 5-year average of $497.8 million and a median of $626.6 million in 2025 frame the typical range for Cash & Equivalents.
• Annual changes were most pronounced in 2022 — Cash & Equivalents plunged 99.24% — and 2024, when it jumped 14156.28%.
• Dolby Laboratories' Cash & Equivalents stood at $626.2 million in 2022, then climbed by 4.9% to $656.8 million in 2023, then decreased by 20.71% to $520.8 million in 2024, then grew by 23.62% to $643.8 million in 2025, then sank by 87.65% to $79.5 million in 2026.
• Business Quant data shows DLB's Cash & Equivalents at $79.5 million in Q1 2026, $643.8 million in Q4 2025, and $701.9 million in Q3 2025.